GE HealthCare Technologies Inc.
GEHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5,143 | $5,006 | $4,777 | $5,319 |
| % Growth | 2.7% | 4.8% | -10.2% | – |
| Cost of Goods Sold | $3,153 | $3,023 | $2,765 | $3,044 |
| Gross Profit | $1,990 | $1,985 | $2,012 | $2,275 |
| % Margin | 38.7% | 39.7% | 42.1% | 42.8% |
| R&D Expenses | $292 | $302 | $344 | $344 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,045 | $1,029 | $1,040 | $1,130 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2 | -$1 | $0 |
| Operating Expenses | $1,337 | $1,329 | $1,383 | $1,474 |
| Operating Income | $653 | $654 | $629 | $801 |
| % Margin | 12.7% | 13.1% | 13.2% | 15.1% |
| Other Income/Exp. Net | -$10 | -$41 | $63 | $33 |
| Pre-Tax Income | $643 | $613 | $692 | $834 |
| Tax Expense | $179 | $113 | $104 | $96 |
| Net Income | $446 | $486 | $564 | $720 |
| % Margin | 8.7% | 9.7% | 11.8% | 13.5% |
| EPS | 0.98 | 1.06 | 1.23 | 1.58 |
| % Growth | -7.5% | -13.8% | -22.2% | – |
| EPS Diluted | 0.98 | 1.06 | 1.23 | 1.57 |
| Weighted Avg Shares Out | 456 | 457 | 457 | 457 |
| Weighted Avg Shares Out Dil | 457 | 458 | 459 | 459 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $6 | $0 | $0 |
| Interest Expense | $111 | $113 | $111 | $111 |
| Depreciation & Amortization | $148 | $148 | $136 | $140 |
| EBITDA | $902 | $874 | $939 | $1,085 |
| % Margin | 17.5% | 17.5% | 19.7% | 20.4% |